Neuronal DNA repair pathways in Huntington's disease pathophysiology
Neuronal DNA repair pathways in Huntington's disease pathophysiology
批准号:
10019604
负责人:
Anna Pluciennik
金额:
$7.8万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-17 至 2022-02-28
关键词:
AffectAgeAge of OnsetAnimal ModelAttenuatedBiological AssayBiotinBiotinylationBrain regionCAG repeatCell ExtractsCellsCorpus striatum structureDNADNA Interstrand CrosslinkingDNA RepairDNA Repair GeneDNA Repair PathwayDNA StructureDNA lesionDataDiseaseFunctional disorderGenesGeneticHela CellsHumanHuntington DiseaseHuntington geneKnock-in MouseKnock-outLaboratoriesLeadLengthLigaseLightLinkMLH1 geneMSH2 geneMSH3 geneMass Spectrum AnalysisMediatingMismatch RepairMismatch Repair Gene InactivationMusNeurodegenerative DisordersNeuronsOnset of illnessPMS1 genePMS2 genePathologic ProcessesPathologyPathway interactionsPatientsPlayProcessProteinsRoleSomatic CellStructureSymptomsSystemTherapeutic InterventionTissuesVariantage relatedbasegene repairgenetic variantgenome wide association studyinduced pluripotent stem cellinsightintergenerationalknock-downmouse modelneuron lossnovelprotein complexprotein misfoldingpublic health relevancerepairedtargeted treatment
中文摘要
亨廷顿氏病(HD)是一种神经退行性疾病,由脑内CAG重复序列的扩张引起。
亨廷顿蛋白(HTT)基因,导致主要在纹状体和皮质的神经元死亡。CAG重复是
高度不稳定,无论是在代际和体细胞。HD患者显示出较高的年龄-
纹状体中CAG重复序列的依赖性体细胞扩增,尽管这种扩增也发生在其他细胞中,
组织中最近对HD患者的全基因组关联研究揭示了存在遗传性
疾病发病年龄的调节剂;这些包括参与DNA修复的几个基因,特别是
DNA错配修复(MSH 3、MLH 1、PMS 2、PMS 1)。此外,对HD小鼠模型的研究表明,
DNA错配修复基因Msh 2、Msh 3、Mlh 1或Mlh 3的基因敲除降低了体细胞的不稳定性,
在纹状体中的CAG重复序列。这些数据表明,CAG重复序列的体细胞扩增可能与
纹状体神经元损失和HD患者的疾病症状发作。因此,在目标1中,我们建议
表征和比较小鼠纹状体和其他小鼠大脑区域的蛋白质组装,
并加工CAG挤出物。我们预计,这些蛋白质复合物可能揭示的机制,
CAG扩增,同时也可能发现与重复不稳定无关的新的病理过程。
在目标2中,我们将在人HEK 293细胞中开发基于邻近生物素化(TurboID)的测定以评估
含有CAG挤出物的DNA上的瞬时和稳定的蛋白质组装体,以期最终应用于
这是一种神经元细胞的方法。敲除关键错配修复基因如MSH 3的影响
或FAN 1对这种DNA损伤的处理也将被评估。这些方法的目的是
鉴定决定CAG挤出是否由FAN 1或错配修复途径处理的蛋白质。
英文摘要
Huntington’s disease (HD) is a neurodegenerative disorder caused by an expansion of a CAG repeat tract within
the huntingtin (HTT) gene, leading to neuronal death primarily in the striatum and the cortex. The CAG repeat is
highly unstable, both intergenerationally and in somatic cells. HD patients display a high degree of age-
dependent somatic expansion of the CAG repeat in the striatum, although such expansions also occur in other
tissues. Recent genome-wide association studies of HD patients have revealed the existence of genetic
modifiers of the age of onset of the disease; these include several genes involved in DNA repair, and in particular
DNA mismatch repair (MSH3, MLH1, PMS2, PMS1). In addition, studies in mouse models of HD have revealed
that genetic knockout of the DNA mismatch repair genes, Msh2, Msh3, Mlh1, or Mlh3 reduces somatic instability
of CAG repeats in the striatum. These data suggest that somatic expansion of CAG repeats is likely linked to
striatal neuronal loss, and onset of disease symptoms in HD patients. Therefore, in Aim 1, we propose to
characterize and compare protein assemblies in mouse striatum and other mouse brain regions that recognize
and process CAG extrusions. We anticipate that these protein complexes may shed light on the mechanism of
CAG expansions, while also potentially uncovering novel pathological processes unrelated to repeat instability.
In Aim 2, we will develop proximity biotinylation (TurboID)-based assay in human HEK293 cells to evaluate
transient and stable protein assemblies on DNA containing CAG extrusions, with a view to eventually applying
this approach to cells of neuronal origin. The effects of knockdown of critical mismatch repair genes like MSH3
or FAN1 on the processing of such DNA lesions will also be evaluated. The objective of these approaches is to
identify proteins that determine whether CAG extrusions are processed by FAN1 or the mismatch repair pathway.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Crosstalk between DNA repair pathways in repeat instability
-
批准号:10595243
-
项目类别:
-
资助金额:$31.2万
-
财政年份:2023
-
负责人:Anna Pluciennik
-
依托单位:
Molecular mechanisms of triplet repeat instability in Huntington's disease
-
批准号:10298851
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2021
-
负责人:Anna Pluciennik
-
依托单位:
Molecular mechanisms of triplet repeat instability in Huntington's disease
-
批准号:10441533
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2021
-
负责人:Anna Pluciennik
-
依托单位:
Molecular mechanisms of triplet repeat instability in Huntington's disease
-
批准号:10683716
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2021
-
负责人:Anna Pluciennik
-
依托单位:
Role of USP7 in pathogenicity of spinal and bulbar muscular atrophy
-
批准号:9375067
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2017
-
负责人:Anna Pluciennik
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: